These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Efficacy of insulin and sulfonylurea combination therapy in type II diabetes. A meta-analysis of the randomized placebo-controlled trials. Johnson JL; Wolf SL; Kabadi UM Arch Intern Med; 1996 Feb; 156(3):259-64. PubMed ID: 8572835 [TBL] [Abstract][Full Text] [Related]
25. Physiology of glucose homeostasis and insulin therapy in type 1 and type 2 diabetes. Ferrannini E Endocrinol Metab Clin North Am; 2012 Mar; 41(1):25-39. PubMed ID: 22575405 [TBL] [Abstract][Full Text] [Related]
26. Preoperative hypoglycemia in a patient receiving insulin detemir. Olson RP; Bethel MA; Lien L Anesth Analg; 2009 Jun; 108(6):1836-8. PubMed ID: 19448209 [TBL] [Abstract][Full Text] [Related]
27. Insulin therapy in type II diabetes: who needs it, how much of it, and for how long? Skyler JS Postgrad Med; 1997 Feb; 101(2):85-90, 92-4, 96. PubMed ID: 9046928 [TBL] [Abstract][Full Text] [Related]
28. Strategies for insulin therapy in type 2 diabetes. Edelman SV; Morello CM South Med J; 2005 Mar; 98(3):363-71. PubMed ID: 15813164 [TBL] [Abstract][Full Text] [Related]
30. [An analysis of the causes of low-efficacy treatment in type-2 diabetes mellitus using sulfonylurea derivatives]. Gendeleka GF Lik Sprava; 1996; (3-4):100-3. PubMed ID: 9035838 [TBL] [Abstract][Full Text] [Related]
31. [Insulin monotherapy in patients with diabetes mellitus type 2 developing secondary resistance to sulfanilamide preparations]. Gendeleka GF Lik Sprava; 2000 Mar; (2):72-4. PubMed ID: 10862482 [TBL] [Abstract][Full Text] [Related]
32. [Principles of diabetes mellitus type 2 therapy regarding some aspects of insulin deficiency development]. Vernyhorods'kyĭ VS Lik Sprava; 2004; (3-4):72-5. PubMed ID: 15318832 [TBL] [Abstract][Full Text] [Related]
34. Non-insulin-dependent diabetes mellitus. Current status of oral hypoglycemic therapy. Nelson RL Postgrad Med; 1987 May; 81(6):177-81, 184-6. PubMed ID: 3554200 [TBL] [Abstract][Full Text] [Related]
35. [The use of the hypoglycemic preparation gliquidone in patients with digestive organ diseases combined with diabetes mellitus]. Degtiareva II; Lodianaia EV; Opanasiuk ND; Palladina OL Lik Sprava; 1995; (7-8):84-7. PubMed ID: 8846383 [TBL] [Abstract][Full Text] [Related]
36. Factors for development of secondary failure to sulfonylurea drugs in non-insulin-dependent diabetes mellitus. Borissova AM; Koev DG; Minev MG; Martinova FG; Gencova PI; Kirilov GG; Arnaudov J Acta Diabetol Lat; 1991; 28(1):91-8. PubMed ID: 1862695 [TBL] [Abstract][Full Text] [Related]
37. Combination insulin-sulfonylurea therapy in type II diabetes mellitus. Allen BT; Feinglos MN South Med J; 1987 Oct; 80(10):1285-9. PubMed ID: 3310252 [No Abstract] [Full Text] [Related]
38. When to use insulin in the maturity onset diabetic. Tattersall RB; Scott AR Postgrad Med J; 1987 Oct; 63(744):859-64. PubMed ID: 3328848 [No Abstract] [Full Text] [Related]
39. Improved insulin sensitivity and metabolic control in type 2 diabetes does not influence plasma homocysteine. Pouwels MJ; Den Heijer M; Blom HJ; Tack CJ; Hermus AR Diabetes Care; 2003 May; 26(5):1637-9. PubMed ID: 12716838 [No Abstract] [Full Text] [Related]
40. [Glurenorm in the treatment of patients with non-insulin-dependent diabetes mellitus with diseases of the liver and bile ducts]. Balabolkin MI; Nedosugova LV Probl Endokrinol (Mosk); 1993; 39(4):16-8. PubMed ID: 8415521 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]